Literature DB >> 6751958

[Controlled double-blind study for the determination of the effect of Tebonin forte in patients with cerebrovascular insufficiency].

F Eckmann, H Schlag.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6751958

Source DB:  PubMed          Journal:  Fortschr Med        ISSN: 0015-8178


× No keyword cloud information.
  7 in total

Review 1.  Complementary and alternative medicines in the treatment of dementia: an evidence-based review.

Authors:  Bruce Diamond; Susan Johnson; Kathleen Torsney; Jennifer Morodan; Brian Prokop; Dana Davidek; Patricia Kramer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 2.  Ginkgo biloba for cerebral insufficiency.

Authors:  J Kleijnen; P Knipschild
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

3.  The comprehensiveness of Medline and Embase computer searches. Searches for controlled trials of homoeopathy, ascorbic acid for common cold and ginkgo biloba for cerebral insufficiency and intermittent claudication.

Authors:  J Kleijnen; P Knipschild
Journal:  Pharm Weekbl Sci       Date:  1992-10-16

Review 4.  [External validity of clinical trials for treatment of dementia with ginkgo biloba extracts].

Authors:  G Bornhöft; S Maxion-Bergemann; P F Matthiessen
Journal:  Z Gerontol Geriatr       Date:  2008-03-11       Impact factor: 1.281

5.  Ginkgo biloba extract in the treatment of tinnitus: a systematic review.

Authors:  Alexander von Boetticher
Journal:  Neuropsychiatr Dis Treat       Date:  2011-07-28       Impact factor: 2.570

6.  A retrospective classification of diagnoses in terms of DSM-5 for patients included in randomized controlled trials of Ginkgo biloba extract EGb 761(®).

Authors:  Robert Hoerr; Michael Zaudig
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-08-13       Impact factor: 5.270

Review 7.  The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention.

Authors:  Brian Giunta; Demian Obregon; Renuka Velisetty; Paul R Sanberg; Cesar V Borlongan; Jun Tan
Journal:  J Neuroinflammation       Date:  2012-08-01       Impact factor: 8.322

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.